MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617072745 A) filed by Gene Company Pty Ltd. on June 11, 2026, for Modified Myoferlin Protein And Method Of Use Thereof To Increase Nanoparticle Payload Release.
Inventor includes Morris, Kevin.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: A modified myoferlin protein capable of being packaged into extracellular vesicles (EVs) to facilitate release of EV payloads into recipient cells. The modified myoferlin protein enhances the release of payload at the targeted site. The present invention further provides a modified myoferlin-encapsulating nanoparticle comprising an exosome encapsulating any embodiment of the modified myoferlin of the present invention and one or more cargo RNAs to enhance release of the cargo RNAs at the targeted site.
Disclaimer: Curated by HT Syndication.
